Chinook Therapeutics Inc.

Historical 13F Holders

Symbol
KDNY
CUSIP
00739L101
All holders as of
Q3 2020
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2020 Q3 67 32.6 M $79.3 M
2020 Q2 97 40.3 M $93.1 M
2020 Q1 85 39.1 M $107 M
2019 Q4 86 32.9 M $38.8 M
2019 Q3 88 32.1 M $34.0 M
2019 Q2 102 33.8 M $52.4 M
2019 Q1 103 33.8 M $134 M
2018 Q4 87 36.4 M $96.1 M
2018 Q3 96 39.4 M $290 M
2018 Q2 93 39.1 M $274 M
2018 Q1 97 37.0 M $344 M
2017 Q4 96 36.4 M $273 M
2017 Q3 93 35.2 M $375 M
2017 Q2 85 26.4 M $301 M
2017 Q1 88 25.2 M $271 M
2016 Q4 92 24.2 M $276 M
2016 Q3 95 24.1 M $299 M
2016 Q2 107 19.5 M $220 M
2016 Q1 96 19.4 M $249 M
2015 Q4 94 18.5 M $521 M
2015 Q3 78 20.0 M $399 M
2015 Q2 81 15.0 M $456 M